Vesicoureteral Reflux Market Research Report- Global Forecast till 2030

Vesicoureteral Reflux Market Research Information: by types (primary, secondary) by diagnosis (cystography, VCUG, others) by drug treatment (quinolones, aminoglycosides, others) by surgery (open, robotic, others) by end users - Global Forecast till 2030

ID: MRFR/Pharma/2665-HCR | 90 Pages | Published By Kinjoll Dey on April 2023         

Table of Contents

1. Introduction

1.1 Definition

1.2 scope of study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3. Market dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market factor analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5. Global Vesicoureteral reflux market, by Types

5.1 Primary Vesicoureteral Reflux

5.2 Secondary Vesicoureteral Reflux

6. Global Vesicoureteral reflux market, By Diagnosis

6.1 Introduction

6.2 Cystography

6.3 Voiding Cystourethrogram (VCUG)

6.4 Ultrasound

6.5 Scintigraphy

6.6 Urinalysis

6.7 Others

7. Global Vesicoureteral reflux market, by Drug Treatment

7.1 Introduction

7.2 Quinolones

7.3 Aminoglycosides

7.4 Β-Lactam

7.5 Azoles

7.6 Others

8. Global Vesicoureteral reflux market, by Surgery (

8.1 Introduction

8.2 Open Surgery

8.3 Robotic-Assisted Laparoscopic Surgery

8.4 Endoscopic Surgery

8.5 Others

9. Global Vesicoureteral reflux market, By End Users

9.1 Hospitals And Clinics

9.2 Academics And Research

9.3 Others

10. Global Vesicoureteral reflux market, By Region

10.1 North America

10.1.1 Introduction

10.2 Europe

10.2.1 Introduction

10.3 Asia-Pacific

10.3.1 Introduction

10.4 Middle East & Africa

10.4.1 Introduction

11. Competitive landscape

11.1 Major Strategies Adopted By Market Players

11.1.1 Strategic Partnership

11.1.2 Merger & Acquisition

12. Company profile

12.1 Salix Pharmaceuticals

12.1.1 Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 Key Developments

12.2 Q-Med Scandinavia Inc.

12.2.1 Overview

12.2.2 Product Overview

12.2.3 Financials

12.2.4 Key Developments

12.3 Cook Medical

12.3.1 Overview

12.3.2 Product Overview

12.3.3 Financials

12.3.4 Key Development

12.4 Salix Pharmaceuticals, Ltd.,

12.4.1 Overview

12.4.2 Product Overview

12.4.3 Financials

12.4.4 Key Developments

12.5 Bayer AG

12.5.1 Overview

12.5.2 Product Overview

12.5.3 Financials

12.5.4 Key Developments

12.6 Novartis AG

12.6.1 Overview

12.6.2 Product Overview

12.6.3 Financials

12.6.4 Key Developments

12.7 Pfizer Inc.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.8 F. Hoffmann-La Roche Ltd

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.9 Others

13. Conclusion

13.1 Key Findings

13.1.1 From Ceo’s Viewpoint

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Vesicoureteral Reflux Diagnosis And Treatment Industry

14. Appendix